STUDIES ON FIXED DOSE COMBINATION OF IBRUTINIB AND QUERCETIN SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS IN HUMAN CANCER CELL LINES. Int. J. Pharm. Sci. Drug Res. 2023, 15 (6), 764-769. https://doi.org/10.25004/IJPSDR.2023.150610.